Why the study?
While short- and medium-term outcomes after CRT have been extensively reported, data on very long-term outcomes (10+ years) remain limited.
Does nonischemic cardiomyopathy compared to ischemic cardiomyopathy improve very long-term survival in patients undergoing CRT-D?
Does nonischemic cardiomyopathy compared to ischemic cardiomyopathy improve very long-term survival in patients undergoing CRT-D?
Answers are grounded in this paper and cite their sources.
Over a very long-term follow-up of more than 10 years, patients with nonischemic cardiomyopathy have significantly higher survival post-CRT-D compared to those with ischemic cardiomyopathy.
BACKGROUND: Cardiac resynchronization therapy with defibrillator therapy (CRT-D) has revolutionized the treatment of heart failure with reduced ejection fraction (EF) among a select group of patients with wide QRS. While outcomes in the short- and medium-term post-CRT have been extensively reported, data on very long-term outcomes (10+ years) are limited. OBJECTIVES: The authors aimed to study outcomes of CRT over very long terms of 10+ years. METHODS: We retrospectively reviewed the records of patients who underwent CRT-D at the Mayo Clinic between January 2001 and September 2022. All patients with an EF ≤35%, QRS ≥120 ms, and CRT-D were included in the analysis. The primary endpoint was all-cause mortality. Double matching-propensity matching followed by univariate and multivariable survival analyses-was conducted using accelerated failure models with a log-logistic distribution. Time ratios (TRs) representing the change in survival for a unit increment change in that variable were reported. RESULTS: Among a matched cohort of 610 patients, post-CRT-D implantation, the average survival was 16.1 years for patients with nonischemic cardiomyopathy (NICM) and 9.1 years for patients with ischemic cardiomyopathy. NICM was associated with increased survival in both univariate (TR: 1.92; P < 0.001) and multivariable (TR: 1.43; P = 0.014) analyses. Other independent predictors of increased survival post-CRT included baseline left bundle branch block morphology, decreasing age, higher left ventricular EF, female gender, and absence of the following comorbidities: atrial fibrillation, type 2 diabetes mellitus, and chronic kidney disease 3 or higher. CONCLUSIONS: Our data suggest that over the very long term (>10 years), patients with NICM had significantly higher survival post-CRT than patients with ischemic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: